Home
About
Overview
Sharing Data
ORCID
Help
History (2)
A phase I human trial of mitoguazone and gemcitabine sequential bi-weekly treatment of cancer patients.
Extracellular glutathione is a source of cysteine for cells that express gamma-glutamyl transpeptidase.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A phase I human trial of mitoguazone and gemcitabine sequential bi-weekly treatment of cancer patients.
A phase I human trial of mitoguazone and gemcitabine sequential bi-weekly treatment of cancer patients. Cancer Invest. 2003; 21(4):542-9.
View in:
PubMed
subject areas
Aged
Aged
Antineoplastic Combined Chemotherapy Protocols
Antineoplastic Combined Chemotherapy Protocols
Deoxycytidine
Deoxycytidine
Dose-Response Relationship, Drug
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Administration Schedule
Female
Female
Humans
Humans
Infusions, Intravenous
Infusions, Intravenous
Male
Male
Middle Aged
Middle Aged
Mitoguazone
Mitoguazone
Neoplasms
Neoplasms
authors with profiles
Hong Liu